Keyphrases
T Cell Response
100%
Varicella Zoster Virus
100%
Fingolimod
100%
MS Patients
100%
Virus-specific
37%
Fingolimod Therapy
37%
Multiple Sclerosis
25%
Peripheral Blood Mononuclear Cells
25%
Epstein-Barr Virus
25%
Saliva
25%
Interferon-γ
25%
Cell Samples
12%
Quantitative PCR
12%
Activation Markers
12%
Immune Response
12%
Healthy Controls
12%
T Cells
12%
Cell number
12%
Absolute Count
12%
Saliva Samples
12%
Viral Replication
12%
Specific Immune Response
12%
Antiviral T Cells
12%
Subclinical Reactivation
12%
Proliferation Assay
12%
CD69
12%
Effector Memory T Cells
12%
Viral Reactivation
12%
Central Memory T Cells
12%
CD137
12%
Interferon-β (IFN-β)
12%
CD31
12%
Epstein-Barr Virus Reactivation
12%
Enzyme-linked Immunosorbent Spot Assay
12%
T Cell Activation Markers
12%
Immunology and Microbiology
Varicella Zoster Virus
100%
Fingolimod
100%
T Cell
100%
Interferon Type I
30%
Epstein Barr Virus
30%
Memory T Cell
20%
Immune Response
20%
Multiple Sclerosis
20%
Peripheral Blood Mononuclear Cell
20%
Viral Replication
10%
Enzyme-Linked Immunospot Assay
10%
T Cell Activation
10%
Cell Proliferation
10%
Upregulation
10%
Real Time Polymerase Chain Reaction
10%
Virus Reactivation
10%
CD69
10%
CD31
10%
Neuroscience
T Cell
100%
Varicella Zoster Virus
100%
Fingolimod
100%
Interferon
30%
Epstein-Barr Virus
30%
Multiple Sclerosis
20%
Peripheral Blood Mononuclear Cell
20%
Real-Time Polymerase Chain Reaction
10%
CD137
10%
Cell Proliferation
10%
Cell Activation
10%
Pharmacology, Toxicology and Pharmaceutical Science
Varicella Zoster Virus
100%
Fingolimod
100%
Epstein-Barr Virus
30%
Interferon
30%
Multiple Sclerosis
20%
Enzyme-Linked Immunospot Assay
10%
Antivirus Agent
10%